Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market trends of capillary blood collection devices have witnessed significant growth and evolution in recent years, driven by advancements in healthcare technology and an increasing emphasis on point-of-care diagnostics. These devices, designed for the convenient and efficient collection of small blood samples from the capillaries, play a crucial role in various medical settings, including clinics, hospitals, and home healthcare.
One notable trend in the capillary blood collection devices market is the growing demand for minimally invasive procedures. Patients and healthcare providers alike are increasingly recognizing the benefits of capillary blood sampling, which offers a less painful and more patient-friendly alternative to traditional venipuncture. This shift is particularly evident in pediatric and geriatric populations, where the ease of use and reduced discomfort associated with capillary blood collection devices contribute to improved patient compliance and overall satisfaction.
Furthermore, technological advancements have spurred innovation in the design and functionality of capillary blood collection devices. Manufacturers are focusing on developing devices that are user-friendly, reliable, and capable of providing accurate results. The integration of features such as automatic lancet activation, adjustable depth settings, and safety mechanisms ensures not only a seamless user experience but also enhances the overall efficiency of blood collection processes. These innovations contribute to the market's expansion as healthcare professionals seek tools that streamline workflows and improve the quality of patient care.
The market is also witnessing a surge in demand for point-of-care testing, driven by the need for rapid and on-the-spot diagnostic results. Capillary blood collection devices play a pivotal role in this trend, as they enable quick and easy sample collection, making them ideal for point-of-care applications. The convenience and speed offered by these devices are especially crucial in emergency situations, where immediate access to diagnostic information can significantly impact treatment decisions.
Geographically, the capillary blood collection devices market is experiencing robust growth in both developed and developing regions. The increased prevalence of chronic diseases, coupled with the growing awareness of the importance of regular health check-ups, has contributed to the market's expansion. Developing economies, in particular, are witnessing a surge in demand for affordable and accessible healthcare solutions, driving the adoption of capillary blood collection devices in primary care settings.
In addition to these trends, the market is also influenced by regulatory developments and standards aimed at ensuring the safety and efficacy of medical devices. Adherence to these regulations is crucial for manufacturers looking to enter or expand their presence in the capillary blood collection devices market. As the industry evolves, collaboration between healthcare providers, regulatory bodies, and industry stakeholders becomes increasingly important to address challenges and foster sustainable growth.
Capillary Blood Collection Devices Market Highlights:
Capillary Blood Collection Devices Market Overview
Capillary Blood Collection Devices Market Size was valued at USD 1.97 Billion in 2023. The Global Capillary Blood Collection Devices industry is projected to grow from USD 2.12 Billion in 2024 to USD 4.02 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.23% during the forecast period (2024 - 2032).
Impact of COVID-19
The outbreak of COVID-19 brought a significant impact on the capillary blood collection devices industry. The lockdown imposed during the pandemic hampered the production and supply chain owing to the temporary shutdown of the manufacturing units.
In December 2023, the Food and Drug Administration (FDA) approved the use of the BD MiniDraw™ Capillary Blood Collection System for obtaining high-quality blood samples from a patient's finger. The device comprises a capillary blood collection tube and a finger sleeve designed for use by a skilled healthcare professional, eliminating the requirement for a phlebotomist. The FDA clearance encompasses the collection of small amounts of blood for a lipid panel, certain chemical assays, and hemoglobin and hematocrit testing. A study was conducted to assess the effectiveness of the BD MiniDraw Collection System. The study involved 45 participants who received formal training on the system prior to performing simulated blood collections. The findings indicated that individuals without formal training in phlebotomy achieved comparable proficiency to those who received training in the utilization of the capillary blood collection device. Furthermore, a comparative investigation demonstrated that there were no significant changes, either statistically or clinically, when analyzing hemoglobin and hematocrit using capillary or venous blood samples.
In October 2023, European regulators granted Tasso Inc. permission to sell its Tasso+ device in the EU. This approval adds another option to the market for blood collection. Tasso has created the Tasso+, a disposable blood lancing device that gathers a little amount of blood from the upper arm. Tasso asserts that it is the inaugural device of its category to receive both the CE mark and U.S. FDA approval.
Capillary Blood Collection Devices Market Trends
Drivers
-
Growing Incidence of Chronic Diseases to Boost the Market
The increasing incidence of chronic ailments among the expanding populace is predicted to be a notable factor that can develop the market during the forecast period. The growing demand for minimally invasive methods is anticipated to be another noteworthy factor that is likely to fuel the need for the device, thereby augmenting the capillary blood sampling devices. Besides, the rising application of the technique in conjugation with PoC diagnostics has become the most chosen method of testing in remote health settings, which is recognized to be another salient cause that may strengthen the capillary blood collection devices industry during the forecast tenure.
Opportunities
-
Rising Requirement for Safe Blood Collection Technologies to Offer Significant Opportunities
The increasing demand for safe blood collection technologies is predicted to be a salient factor that is expected to offer a significant opportunity for market expansion during the review period.
Restraints
-
Risks Associated with the Capillary Blood Assortment Technology to Hamper the Market
The high risks associated with the capillary blood collection devices and the capillary blood assortment technologies are expected to be a salient cause that can hamper the market growth during the assessment tenure.
Challenges
-
Disadvantages of Micro-Collection of Blood to Pose a Significant Challenge
The disadvantages of micro-collection of blood and the scope of blood contaminations are anticipated to pose a significant challenge that is likely to obstruct the market expansion during the review tenure.
Cumulative Market Growth Analysis
MRFR asserts that the global capillary blood collection market is anticipated to experience significant market growth while thriving at a CAGR of 10% during the analysis timeframe. The expansion of the market can be attributed to the growing incidence of chronic illness.
Capillary Blood Collection Devices Market Segment Insights
Capillary Blood Collection Devices Material Insights
In the material segment of the global capillary blood collection devices market, the plastic devices segment is anticipated to dominate the market during the forecast period. The development of the segment can be attributed to the extensive application of plastic for the production of various medical equipment owing to its cost-effectiveness. On the other hand, the glass segment is also projected to acquire significant traction during the forecast period.
Capillary Blood Collection Devices End-User Insights
In the end-user segment of the global capillary blood collection devices market, the hospitals and clinics segment is anticipated to acquire significant traction during the forecast period. The segment had acquired a market value of USD 190.36 million in 2019.
Capillary Blood Collection Devices Type of Devices Insights
In the type of devices segment of the global capillary blood collection devices market, the lancets segment is anticipated to grow significantly during the forecast period. The expansion of the segment is projected to the rising demand for minimum invasiveness during blood collection.
Regional Analysis
North America to Lead the Global Market
North America is expected to dominate the market during the forecast period owing to the increasing demand for minimally invasive surgeries method. The rising incidences of chronic ailments among the rising populace are expected to further grow the need for the product, thereby developing the market growth. In addition, the substantial participation of established players in the region is likely to strengthen the market in the region. Among all, the US is anticipated to make the most crucial participation in developing the market during the forecast period.
Europe to Acquire the Second Largest Market Share
Europe is estimated to acquire the second largest market share during the forecast period. The expansion of the regional market can be attributed to the rising R&D and the growing prevalence of chronic illness among the expanding populace. In addition, the increasing initiatives of partnership among key players of the region are projected to play a salient role in developing the market in the region.
APAC to be the Fastest Growing Region
APAC is anticipated to be the fastest-growing region of the market during the projection tenure. The growing initiatives to develop the healthcare sector in the developing countries are expected to develop the market during the projection timeframe. In addition, the rising prevalence of chronic illnesses such as diabetes is recognized to be another salient cause that can augment the market in the region.
MEA to Acquire the Least Market Share
MEA is expected to acquire the least market share during the forecast period. The presence of underdeveloped countries is likely to be a significant cause that may hamper the market growth in the region.
Competitive Analysis
Various players of the market are adopting strategies such as partnerships, mergers, and acquisitions to gain higher impetus in the global market while also focusing on expanding their product portfolio. The growing incidence of chronic illness has led to a higher demand for innovative methods for which players are concentrating on the launch of new products, which has increased the competition among the players in the industry.
List of Key Players Covered in the Report
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Abbott Laboratories
- Novo Nordisk AS
- Becton Dickinson and Company
- Medtronic PLC
- B. Braun Melsungen AG
- Thermo Fisher Scientific Inc.
- Terumo Corporation
- Ypsomed Holding AG
- HTL-STREFA SA
- Sarstedt AG & Co
- Owen Mumford Ltd
- Greiner Bio-One
- Improve Medical
- Chengdu Rich Science Industry Co., Ltd.
Recent Developments
January 2021- Becton Dickinson and Company, a renowned global medical technology company, announced Tom Polen, as the BD CEO and President.
January 2021- Medtronic has announced the first enrolment in its trial evaluating the safety of adaptive deep brain stimulation (aDBS) in patients with Parkinson’s disease.
Report Overview
The report on the global capillary blood collection devices market comprises primary challenges, opportunities, drivers, and restraints that bring a significant impact on the market. MRFR critically assess the market size, taking into account the base year and the projected year. The report also studies the impact of COVID-19. Apart from comprehensive market segmentation, the report also highlights the latest business scenario. In addition, the report also comprises well-known vendors and the top strategies followed by them to stay competitive in the industry.
Capillary Blood Collection Devices Market Segmentation
Capillary Blood Collection Devices Material Outlook
- Plastic
- Glass
- Stainless Steel
- Others
Capillary Blood Collection Devices End-User Outlook
- Hospitals & Clinics
- Diagnostic Centers and Pathology Laboratories
- Home Diagnostics
- Others
Capillary Blood Collection Devices Type of Devices Outlook
- Blood Collecting Tubes and Collector
- Lancets
- Warming Devices
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
